Safety and efficacy of cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: results of a Japanese post-marketing surveillance study

OBJECTIVE: To evaluate the real-world safety and efficacy of cabazitaxel in Japanese patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with a docetaxel-containing regimen. METHODS: This prospective multicenter observational study registered all patients with mC...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Kazuhiro, Matsubara, Nobuaki, Kazama, Hirotaka, Seto, Takeshi, Tsukube, Shoko, Matsuyama, Hideyasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933873/
https://www.ncbi.nlm.nih.gov/pubmed/31361807
http://dx.doi.org/10.1093/jjco/hyz108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933873/
https://www.ncbi.nlm.nih.gov/pubmed/31361807
http://dx.doi.org/10.1093/jjco/hyz108

Ejemplares similares